HBSP (USA)
-
Alvogen: Scaling Entrepreneurship, Teaching Note
Kerr, William R.; Isenberg, Daniel J.Teaching Note HBS-820020-EEntrepreneurshipTeaching note for case 819038.Starting at €0.00
-
Iceland (A) and (B), Teaching Note
Musacchio, AldoTeaching Note HBS-710052-EFinanceTeaching Note for [709011] and [709012].Starting at €0.00
-
Alvogen: Scaling Entrepreneurship
Isenberg, Daniel J.; Kerr, William R.; Brownell, AlexisCase HBS-819038-EEntrepreneurshipStarting at €8.20
-
Iceland (A)
Musacchio, AldoCase HBS-709011-EFinanceIn May of 2008, a team of sovereign debt analysts at Moody's had to decide whether to downgrade the country's sovereign long-term debt from Aaa to Aa1 or lower. Investor sentiment toward Iceland had changed radically in March, and the Moody's team was fearful that the situation could spiral out of control. The Moody's team knew that carry traders increased Iceland's vulnerability to a confidence crisis because they were quick to liquidate their h...Starting at €8.20
-
Iceland (B): Redefining Aaa-Rated Sovereigns
Musacchio, AldoCase HBS-709012-EFinanceIn May of 2008, a team of sovereign debt analysts at Moody's had to decide whether to downgrade the country's sovereign long-term debt from Aaa to Aa1 or lower. Investor sentiment toward Iceland had changed radically in March, and the Moody's team was fearful that the situation could spiral out of control. The Moody's team knew that carry traders increased Iceland's vulnerability to a confidence crisis because they were quick to liquidate their h...Starting at €5.74
-
Alvogen
Isenberg, Daniel; Kerr, William R.Case HBS-816064-EStrategyAlvogen is a young Icelandic generic pharmaceutical company, whose CEO believes that his global strategy will give them an edge in this competitive industry. Robert Wessman, Alvogen's CEO, was also previously the CEO of Actavis, another Icelandic genericStarting at €8.20